QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 First-in-human study of Lu-177-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 期刊论文 2019, 卷号: 46, 期号: 1, 页码: 148-158 作者:  Zang, Jie;  Fan, Xinrong;  Wang, Hao;  Liu, Qingxing;  Wang, Jingnan 收藏  |  浏览/下载：27/0  |  提交时间：2020/01/03 Radioligand therapy (RLT)  Lu-177  Evans blue  Prostate-specific membrane antigen (PSMA)  Metastatic castration-resistant prostate cancer (mCRPC)   Pretherapeutic Ga-68-PSMA-617 PET May Indicate the Dosimetry of Lu-177-PSMA-617 and Lu-177-EB-PSMA-617 in Main Organs and Tumor Lesions 期刊论文 2019, 卷号: 44, 期号: 6, 页码: 431-438 作者:  Wang, Jingnan;  Zang, Jie;  Wang, Hao;  Liu, Qingxing;  Li, Fang 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03 Ga-68  Lu-177  prostate-specific membrane antigen (PSMA)  metastatic castration-resistant prostate cancer (mCRPC)  dosimetry   A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy naive patients with mCRPC in China, Malaysia, Thailand and Russia 期刊论文 ASIAN JOURNAL OF UROLOGY, 2017, 卷号: 4, 期号: 2 作者:  Ye, Dingwei;  Huang, Yiran;  Zhou, Fangjian;  Xie, Keji;  Matveev, Vsevolod 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Abiraterone  Chemotherapy-naive  Metastatic castration-resistant prostate cancer  Prostate specific antigen  Prednisone   A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia 期刊论文 2017, 卷号: 4, 期号: 2, 页码: 75-85 作者:  Ye Dingwei;  Huang Yiran;  Zhou Fangjian;  Xie Keji;  Matveev Vsevolod 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/04 Abiraterone  Chemotherapy-naïve  Metastatic castration-resistant prostate cancer  Prednisone  Prostate specific antigen   Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells 期刊论文 THERANOSTICS, 2017, 卷号: 7, 期号: 7, 页码: 1914-1927 作者:  Han, Yangyang;  Huang, Weiwei;  Liu, Jiakuan;  Liu, Dandan;  Cui, Yangyan 收藏  |  浏览/下载：52/0  |  提交时间：2019/01/08 Triptolide  Enzalutamide  Castration-resistant prostate cancer  Androgen receptor  Phosphorylation   Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study 会议论文 作者:  Ahn, H.;  Ye, D.;  Pu, Y-S.;  Han, W.;  Xie, L-P. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study 会议论文 作者:  Ye, D.;  Ahn, H.;  Pu, Y-S.;  Weiqing, H.;  Xie, L-P. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer 期刊论文 ONCOGENE, 2016 Ruscetti, M.; Dadashian, E. L.; Guo, W.; Quach, B.; Mulholland, D. J.; Park, J. W.; Tran, L. M.; Kobayashi, N.; Bianchi-Frias, D.; Xing, Y.; Nelson, P. S.; Wu, H. 收藏  |  浏览/下载：2/0  |  提交时间：2017/12/03 ANDROGEN RECEPTOR  BREAST-CANCER  DNA-BINDING  INCREASED SURVIVAL  STEM-CELLS  PTEN LOSS  HMGI-C  ACETYLATION  ACTIVATION  EXPRESSION   Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU plus P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC). 会议论文 作者:  Ou, Y.;  Michaelson, M. D.;  Sengelov, L.;  Saad, F.;  Houede, N. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19 Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU+P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC) 期刊论文 Journal of Clinical Oncology, 2011, 卷号: 29 作者:  Ou Y., Michaelson M.D., Sengel酶v L., Saad F., Houede N., Ostler P.J., Stenzl A., Daugaard G., Jones R.J., Laestadius F., Bahl A., Castellano D.E., Gschwend J., Maurina T., Ye D., Chen I., Wang S., Man 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19